Arlington Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $17.2K | Buy |
155
+5
| +3% | +$554 | ﹤0.01% | 456 |
|
2025
Q1 | $16.8K | Sell |
150
-47
| -24% | -$5.27K | ﹤0.01% | 473 |
|
2024
Q4 | $18.2K | Buy |
197
+47
| +31% | +$4.34K | ﹤0.01% | 425 |
|
2024
Q3 | $12.6K | Sell |
150
-86
| -36% | -$7.21K | ﹤0.01% | 437 |
|
2024
Q2 | $16.2K | Sell |
236
-150
| -39% | -$10.3K | ﹤0.01% | 416 |
|
2024
Q1 | $28.3K | Sell |
386
-173
| -31% | -$12.7K | 0.01% | 314 |
|
2023
Q4 | $45.3K | Buy |
559
+536
| +2,330% | +$43.4K | 0.01% | 292 |
|
2023
Q3 | $1.72K | Buy |
+23
| New | +$1.72K | ﹤0.01% | 280 |
|